Caorui Lin

408 total citations
23 papers, 291 citations indexed

About

Caorui Lin is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Caorui Lin has authored 23 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Epidemiology and 8 papers in Hepatology. Recurrent topics in Caorui Lin's work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Muscle Physiology and Disorders (8 papers). Caorui Lin is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Muscle Physiology and Disorders (8 papers). Caorui Lin collaborates with scholars based in China, Singapore and United States. Caorui Lin's co-authors include HaiFang Yin, Ning Ran, Xianjun Gao, Mengyuan Geng, Xue Dong, Gang Han, Yiqi Seow, Qishui Ou, Tianbin Chen and Xianfu Yi and has published in prestigious journals such as Biomaterials, Gut and Cell Death and Differentiation.

In The Last Decade

Caorui Lin

22 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caorui Lin China 10 212 53 36 31 24 23 291
Xiaofeng Yuan China 13 180 0.8× 47 0.9× 24 0.7× 14 0.5× 20 0.8× 34 354
Gabriel Gallo-Oller Spain 8 198 0.9× 51 1.0× 23 0.6× 13 0.4× 15 0.6× 20 315
Rosa Elena Huerta Hernández Spain 7 127 0.6× 38 0.7× 16 0.4× 21 0.7× 13 0.5× 17 270
Di Ding China 10 180 0.8× 127 2.4× 47 1.3× 12 0.4× 15 0.6× 22 305
Yaxing Xu China 8 283 1.3× 130 2.5× 67 1.9× 22 0.7× 7 0.3× 12 387
Jolanta Hybiak Poland 9 93 0.4× 28 0.5× 16 0.4× 14 0.5× 19 0.8× 12 276
Etsuko Matsuzaki Japan 12 249 1.2× 41 0.8× 23 0.6× 37 1.2× 15 0.6× 23 361
Yue Teng China 13 160 0.8× 102 1.9× 46 1.3× 11 0.4× 18 0.8× 32 393
Mohamed S. Hussein United States 9 141 0.7× 58 1.1× 15 0.4× 24 0.8× 11 0.5× 14 327
Li Fang Koh Singapore 6 113 0.5× 52 1.0× 23 0.6× 24 0.8× 11 0.5× 9 300

Countries citing papers authored by Caorui Lin

Since Specialization
Citations

This map shows the geographic impact of Caorui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caorui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caorui Lin more than expected).

Fields of papers citing papers by Caorui Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caorui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caorui Lin. The network helps show where Caorui Lin may publish in the future.

Co-authorship network of co-authors of Caorui Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Caorui Lin. A scholar is included among the top collaborators of Caorui Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caorui Lin. Caorui Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xun, Zhen, Caorui Lin, Yanfang Zhang, et al.. (2025). A novel therapy targeting the gut–liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium. JHEP Reports. 7(8). 101456–101456.
2.
Lin, Caorui, Ying Huang, Ning Ran, et al.. (2025). Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α. Gut. 74(12). 2035–2049. 1 indexed citations
3.
Xun, Zhen, Caorui Lin, Tianbin Chen, et al.. (2024). Characterization of BCP/PreC/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencing. International Journal of Medical Microbiology. 315. 151619–151619. 1 indexed citations
4.
Han, Gang, Yao Zhang, Zhong Li, et al.. (2024). Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes. EMBO Molecular Medicine. 16(4). 1027–1045. 9 indexed citations
5.
Zhang, Li, Huanhuan Huang, Tianbin Chen, et al.. (2024). Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury. Gut Microbes. 16(1). 2323236–2323236. 15 indexed citations
6.
Zeng, Yongbin, Zhen Xun, Yanfang Zhang, et al.. (2023). Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B. Clinica Chimica Acta. 553. 117739–117739. 1 indexed citations
7.
Ye, Yuchen, Caorui Lin, Ye Shen, et al.. (2023). Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling. Cellular and Molecular Gastroenterology and Hepatology. 17(2). 219–235. 7 indexed citations
8.
Wang, Long, Yanfang Zhang, Can Liu, et al.. (2023). A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B. Microbiology Spectrum. 11(6). e0224723–e0224723. 3 indexed citations
9.
Lin, Caorui & Qishui Ou. (2022). Emerging role of mitochondria in response to HBV infection. Journal of Clinical Laboratory Analysis. 36(10). 6 indexed citations
10.
Ran, Ning, Renjie Zhang, Caorui Lin, et al.. (2022). Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury. Bioactive Materials. 25. 766–782. 51 indexed citations
11.
Han, Gang, Caorui Lin, & HaiFang Yin. (2022). Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy. Methods in molecular biology. 2587. 165–182. 1 indexed citations
12.
Lin, Caorui, Ying Huang, Linjie Luo, et al.. (2022). Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression. Frontiers in Immunology. 13. 927761–927761. 7 indexed citations
13.
Chen, Tianbin, Yongbin Zeng, Di Yang, et al.. (2022). Nomogram Model for Prediction of SARS-CoV-2 Breakthrough Infection in Fujian: A Case–Control Real-World Study. Frontiers in Cellular and Infection Microbiology. 12. 932204–932204. 2 indexed citations
14.
Geng, Mengyuan, Yuting Huang, Gang Han, et al.. (2022). Upregulation of Wilms’ Tumor 1 in epicardial cells increases cardiac fibrosis in dystrophic mice. Cell Death and Differentiation. 29(10). 1928–1940. 7 indexed citations
15.
Xun, Zhen, Tianbin Chen, Yongbin Zeng, et al.. (2022). Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach. Materials Today Bio. 15. 100302–100302. 11 indexed citations
16.
Ran, Ning, Xianjun Gao, Xue Dong, et al.. (2020). Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice. Biomaterials. 236. 119826–119826. 82 indexed citations
17.
Lin, Caorui, Gang Han, Ning Ran, et al.. (2020). Glycine Enhances Satellite Cell Proliferation, Cell Transplantation, and Oligonucleotide Efficacy in Dystrophic Muscle. Molecular Therapy. 28(5). 1339–1358. 31 indexed citations
18.
Han, Gang, Ben J. Gu, Caorui Lin, et al.. (2019). Hexose Potentiates Peptide-Conjugated Morpholino Oligomer Efficacy in Cardiac Muscles of Dystrophic Mice in an Age-Dependent Manner. Molecular Therapy — Nucleic Acids. 18. 341–350. 7 indexed citations
19.
Han, Gang, et al.. (2018). Long-Term Morpholino Oligomers in Hexose Elicit Long-Lasting Therapeutic Improvements in mdx Mice. Molecular Therapy — Nucleic Acids. 12. 478–489. 10 indexed citations
20.
Cao, Limin, Gang Han, Caorui Lin, et al.. (2016). Fructose Promotes Uptake and Activity of Oligonucleotides With Different Chemistries in a Context-dependent Manner in mdx Mice. Molecular Therapy — Nucleic Acids. 5(6). e329–e329. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026